Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 20;2025(8):omaf140.
doi: 10.1093/omcr/omaf140. eCollection 2025 Aug.

A new case of Tropheryma whipplei infective endocarditis

Affiliations
Case Reports

A new case of Tropheryma whipplei infective endocarditis

Rova Malala Fandresena Randrianarisoa et al. Oxf Med Case Reports. .

Abstract

Introduction: Infective endocarditis is a rare complication of untreated Whipple's disease. We present a case of infective endocarditis caused by Tropheryma whipplei in an aortic bioprosthesis.

Case presentation: A 77-year-old man with a bioprosthetic aortic valve and pacemaker presented with two months of fever. He had a history of HLA-B27-negative ankylosing spondylitis treated with adalimumab. Examination revealed a systolic aortic murmur. Transthoracic echocardiography revealed vegetation on the aortic bioprosthetis. Serologies and cultures were negative. He underwent valve replacement, endocavitary pacemaker system removal, and epicardial pacemaker implantation. Valve tissue PCR and 16S rRNA sequencing were positive for T. whipplei. Empiric ceftriaxone was given for two weeks, followed by doxycycline and hydroxychloroquine for 12 months, then lifelong doxycycline monotherapy.

Conclusion: Whipple's endocarditis is difficult to diagnose due to its atypical presentation and frequent failure to meet Duke criteria. Tissue PCR plays a crucial role when standard microbiologic testing is inconclusive.

Keywords: T. whipplei infective endocarditis; Tropheryma whipplei; blood culture; infective endocarditis; polymerase chain reaction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Transthoracic echocardiographic findings in our patient. (A) Thickening of the aortic valve with visible vegetation (yellow arrow). (B) Magnified view of image a, highlighting the vegetation on the aortic valve (yellow arrow). (C) Five-chamber e chocardiographic view showing vegetation on the aortic valve (yellow highlight). (D) Continuous-wave Doppler assessment of the aortic valve in the five-chamber view, demonstrating flow characteristics consistent with severe aortic stenosis. AO: Aorta; LA: Left atrium; LV: Left ventricle.

References

    1. Marth T, Moos V, Müller C. et al. Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis 2016;16:e13–22. 10.1016/S1473-3099(15)00537-X - DOI - PubMed
    1. Dolmans RA, Boel CH, Lacle MM. et al. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev 2017;30:529–55. 10.1128/CMR.00033-16 - DOI - PMC - PubMed
    1. Lagier JC, Raoult D. Whipple’s disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them. Curr Opin Infect Dis 2018;31:463–70. 10.1097/QCO.0000000000000489 - DOI - PubMed
    1. Fenollar F, Célard M, Lagier JC. et al. Tropheryma whipplei endocarditis. Emerg Infect Dis 2013;19:1721–30. 10.3201/eid1911.121356 - DOI - PMC - PubMed
    1. Østergaard L, Pries-Heje MM, Hasselbalch RB. et al. Accelerated treatment of endocarditis-the POET II trial: rationale and design of a randomized controlled trial. Am Heart J 2020;227:40–6. 10.1016/j.ahj.2020.05.012 - DOI - PubMed

Publication types